PlainRecalls
FDA Devices Moderate Class II Ongoing

Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09

Reported: September 24, 2025 Initiated: July 8, 2025 #Z-2558-2025

Product Description

Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09

Reason for Recall

Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of therapy, return of symptoms and/or Bluetooth connectivity challenges.

Details

Units Affected
25,260
Distribution
Worldwide - US Nationwide distribution including in the states of MN, FL, CO, MD, NY, NE, PA, WI, AZ, TN, MO, TX, MI, MT, MA, WV, AL, VA, NC, CA, OR, WA, LA, OH, NJ, NH, SD, GA, CT, NV, UT, IN, ID, IL, ME, SC, DC, OK, KY, AK, HI, RI, AR, KS, NM and the countries of Argentina, Brazil, Chile, Ecuador, Colombia , Mexico, Canada, Japan, Algeria, Austria, Azerbaijan, Belgium, Bulgaria, Croatia, Denmark, Egypt, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Iran, Ireland, Israel, Italy, Jordan, Kazakhstan, Kuwait, Lebanon, Libya, Luxembourg, Malta, Morocco, Netherlands, Norway, Pakistan, Poland, Portugal, Romania, Russian Fed., Saudi Arabia, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkiye, UAE, Ukraine, United Kingdom, Hong Kong, China, Singapore, Korea, Taiwan , India, Thailand.
Location
Valencia, CA

Frequently Asked Questions

What product was recalled?
Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09. Recalled by Boston Scientific Neuromodulation Corporation. Units affected: 25,260.
Why was this product recalled?
Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of therapy, return of symptoms and/or Bluetooth connectivity challenges.
Which agency issued this recall?
This recall was issued by the FDA Devices on September 24, 2025. Severity: Moderate. Recall number: Z-2558-2025.